Literature DB >> 10374692

CD28/CTLA-4 and CD80/CD86 families: signaling and function.

J M Slavik1, J E Hutchcroft, B E Bierer.   

Abstract

T cell stimulation in the absence of a second, costimulatory signal can lead to anergy or the induction of cell death. CD28 is a major T cell costimulatory receptor, the coengagement of which can prevent anergy and cell death. The CD28 receptor is a member of a complex family of polypeptides that includes at least two receptors and two ligands. Cytotoxic lymphocyte-associated molecule-4 (CTLA-4, CD152) is the second member of the CD28 receptor family. The ligands or counterreceptors for these two proteins are the B7 family members, CD80 (B7-1) and CD86 (B7-2). This article reviews the CD28/CTLA4 and CD80/CD86 families, and outlines the functional outcomes and biochemical signaling pathways recruited after CD28 ligation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374692     DOI: 10.1007/BF02786473

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  196 in total

1.  Absence of B7-dependent responses in CD28-deficient mice.

Authors:  J M Green; P J Noel; A I Sperling; T L Walunas; G S Gray; J A Bluestone; C B Thompson
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

Review 2.  Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity.

Authors:  E C Guinan; J G Gribben; V A Boussiotis; G J Freeman; L M Nadler
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

Review 3.  The T cell receptor/CD3 complex: a dynamic protein ensemble.

Authors:  H Clevers; B Alarcon; T Wileman; C Terhorst
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

4.  CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.

Authors:  E A Tivol; S D Boyd; S McKeon; F Borriello; P Nickerson; T B Strom; A H Sharpe
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

Review 5.  T cell antigen receptor signal transduction pathways.

Authors:  D Cantrell
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

6.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

7.  Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line.

Authors:  A August; B Dupont
Journal:  Biochem Biophys Res Commun       Date:  1994-03-30       Impact factor: 3.575

8.  CD28 signal transduction pathways. A comparison of B7-1 and B7-2 regulation of the map kinases: ERK2 and Jun kinases.

Authors:  J A Nunes; M Battifora; J R Woodgett; A Truneh; D Olive; D A Cantrell
Journal:  Mol Immunol       Date:  1996-01       Impact factor: 4.407

9.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.

Authors:  B M Burgering; P J Coffer
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

10.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  41 in total

Review 1.  Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

Review 2.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter.

Authors:  Heather M Gibson; Carrie J Hedgcock; Barbara M Aufiero; Adam J Wilson; Mikehl S Hafner; George C Tsokos; Henry K Wong
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 5.  Regulatory T cells: immune suppression and beyond.

Authors:  Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

6.  The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.

Authors:  Richard B Kennedy; Whitney L Simon; Michael J Gibson; Krista M Goergen; Diane E Grill; Ann L Oberg; Gregory A Poland
Journal:  Immunology       Date:  2016-05-17       Impact factor: 7.397

7.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

8.  Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.

Authors:  H Ayukawa; T Matsubara; M Kaneko; M Hasegawa; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury.

Authors:  Xiaoling Li; Irshad H Chaudry; Mashkoor A Choudhry
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

Review 10.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.